113 related articles for article (PubMed ID: 2011084)
1. Mechanisms of the glucose lowering effect of a carnitine palmitoyl transferase inhibitor in normal and diabetic rats.
Martin C; Odeon M; Cohen R; Beylot M
Metabolism; 1991 Apr; 40(4):420-7. PubMed ID: 2011084
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mitochondrial carnitine palmitoyl transferase A in vivo with methyl 2-tetradecylglycidate (methyl palmoxirate) and its relationship to ketonemia and glycemia.
Tutwiler GF; Brentzel HJ; Kiorpes TC
Proc Soc Exp Biol Med; 1985 Feb; 178(2):288-96. PubMed ID: 3969383
[TBL] [Abstract][Full Text] [Related]
3. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir.
Schmitz FJ; Rösen P; Reinauer H
Horm Metab Res; 1995 Dec; 27(12):515-22. PubMed ID: 8750778
[TBL] [Abstract][Full Text] [Related]
4. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.
Sako Y; Grill VE
Endocrinology; 1990 Oct; 127(4):1580-9. PubMed ID: 1698143
[TBL] [Abstract][Full Text] [Related]
5. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase.
Brady PS; Brady LJ
Biochem J; 1986 Sep; 238(3):801-9. PubMed ID: 3800962
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal changes of plasma glucose and ketone bodies in fasted and acutely diabetic rats after CNS stimulation.
Iguchi A; Miura H; Kunoh Y; Mizuno S; Uemura K; Ishiguro T; Tamagawa T; Goshima K; Sakamoto N
Life Sci; 1991; 49(16):1191-6. PubMed ID: 1895876
[TBL] [Abstract][Full Text] [Related]
7. Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats.
Collier GR; Traianedes K; Macaulay SL; O'Dea K
Horm Metab Res; 1993 Jan; 25(1):9-12. PubMed ID: 8428713
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemic effects of a novel fatty acid oxidation inhibitor in rats and monkeys.
Deems RO; Anderson RC; Foley JE
Am J Physiol; 1998 Feb; 274(2):R524-8. PubMed ID: 9486313
[TBL] [Abstract][Full Text] [Related]
9. Glucose and ketone body turnover in carnitine-palmitoyl-transferase deficiency.
Nosadini R; Angelini C; Trevisan C; Vigili de Kreutzenberg S; Fioretto P; Trevisan R; Avogaro A; De Dona C; Doria A; Cobelli C
Metabolism; 1987 Sep; 36(9):821-6. PubMed ID: 3626864
[TBL] [Abstract][Full Text] [Related]
10. Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats.
Tessari P; Meneghel A; Avogaro A; Nosadini R; Del Prato S; Tiengo A
Horm Metab Res; 1985 Jun; 17(6):271-4. PubMed ID: 3160642
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus.
Ratheiser K; Schneeweiss B; Waldhäusl W; Fasching P; Korn A; Nowotny P; Rohac M; Wolf HP
Metabolism; 1991 Nov; 40(11):1185-90. PubMed ID: 1943747
[TBL] [Abstract][Full Text] [Related]
12. Influence of carnitine acyltransferase inhibitors on the performance and metabolism of rat cardiac muscle.
Reinauer H; Adrian M; Rösen P; Schmitz FJ
J Clin Chem Clin Biochem; 1990 May; 28(5):335-9. PubMed ID: 2380671
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated, perfused hearts of streptozotocin-diabetic rats.
Rösen P; Reinauer H
Metabolism; 1984 Feb; 33(2):177-85. PubMed ID: 6694560
[TBL] [Abstract][Full Text] [Related]
14. Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines.
Jenkins DL; Griffith OW
Proc Natl Acad Sci U S A; 1986 Jan; 83(2):290-4. PubMed ID: 3455765
[TBL] [Abstract][Full Text] [Related]
15. Lowering of plasma glucose in diabetic rats by antilipolytic agents.
Reaven GM; Chang H; Ho H; Jeng CY; Hoffman BB
Am J Physiol; 1988 Jan; 254(1 Pt 1):E23-30. PubMed ID: 2962514
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitors of beta-oxidation of fatty acids (review)].
Kendysh IN
Vopr Med Khim; 1984; 30(2):18-27. PubMed ID: 6377685
[No Abstract] [Full Text] [Related]
17. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
Bitar MS
Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
[TBL] [Abstract][Full Text] [Related]
19. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes.
Reaven GM; Chang H; Hoffman BB
Diabetes; 1988 Jan; 37(1):28-32. PubMed ID: 3275556
[TBL] [Abstract][Full Text] [Related]
20. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats.
Lopaschuk GD; Spafford M
Circ Res; 1989 Aug; 65(2):378-87. PubMed ID: 2526694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
